RiverFront Investment Group’s Franklin FTSE Japan ETF FLJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27M Buy
747,452
+70,732
+10% +$2.62M 0.42% 53
2025
Q4
$23.3M Buy
676,720
+17,061
+3% +$602K 0.38% 54
2025
Q3
$22.9M Buy
659,659
+26,697
+4% +$889K 0.4% 54
2025
Q2
$20.3M Buy
632,962
+18,435
+3% +$563K 0.4% 53
2025
Q1
$18.1M Buy
614,527
+59,260
+11% +$1.74M 0.4% 57
2024
Q4
$15.9M Buy
555,267
+28,093
+5% +$823K 0.36% 57
2024
Q3
$16M Buy
527,174
+41,387
+9% +$1.22M 0.38% 55
2024
Q2
$14M Buy
485,787
+38,840
+9% +$1.15M 0.37% 53
2024
Q1
$13.9M Buy
446,947
+98,696
+28% +$2.91M 0.39% 50
2023
Q4
$9.75M Buy
348,251
+18,823
+6% +$504K 0.31% 51
2023
Q3
$8.71M Buy
329,428
+16,228
+5% +$439K 0.31% 51
2023
Q2
$8.47M Buy
313,200
+11,207
+4% +$297K 0.28% 52
2023
Q1
$7.81M Buy
301,993
+11,132
+4% +$279K 0.28% 52
2022
Q4
$1.52M Buy
+290,861
New +$6.78M 0.35% 57

Other funds holding FLJP

RiverFront Investment Group's FLJP Position: Q1 2026 in Review

RiverFront Investment Group increased its Franklin FTSE Japan ETF (FLJP) stake by 10% in Q1 2026, buying an estimated $2.62M and bringing the position to 747,452 shares worth $27M. The position accounts for 0.42% of the portfolio, ranked #53.

RiverFront Investment Group first reported a position in FLJP in Q4 2022 and has held it in 14 quarters since. 180 funds tracked by Wall St. Rank hold FLJP as of Q1 2026.

  • RiverFront Investment Group held 747,452 shares of Franklin FTSE Japan ETF worth $27M as of Q1 2026.
  • RiverFront Investment Group bought 70,732 Franklin FTSE Japan ETF shares in Q1 2026, an estimated $2.62M.
  • Franklin FTSE Japan ETF made up 0.42% of RiverFront Investment Group's portfolio in Q1 2026, its #53 holding.
  • RiverFront Investment Group first reported a position in Franklin FTSE Japan ETF in Q4 2022 and has held it in 14 quarters since.
  • 180 funds tracked by Wall St. Rank held Franklin FTSE Japan ETF as of Q1 2026.

Based on RiverFront Investment Group's 13F filing for Q1 2026, filed 11 May 2026.